These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31893946)

  • 1. Advances in the pharmacological management of obsessive-compulsive disorder in the postpartum period.
    Brakoulias V; Viswasam K; Dwyer A; Raine KH; Starcevic V
    Expert Opin Pharmacother; 2020 Feb; 21(2):163-165. PubMed ID: 31893946
    [No Abstract]   [Full Text] [Related]  

  • 2. Postpartum onset obsessive-compulsive disorder: diagnosis and management.
    Brandes M; Soares CN; Cohen LS
    Arch Womens Ment Health; 2004 Apr; 7(2):99-110. PubMed ID: 15083345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive-compulsive disorder.
    Bokor G; Anderson PD
    J Pharm Pract; 2014 Apr; 27(2):116-30. PubMed ID: 24576790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal event-related potential study of selective serotonin reuptake inhibitor therapy in treatment-naïve pediatric obsessive compulsive disorder patients.
    Yamamuro K; Ota T; Iida J; Kishimoto N; Nakanishi Y; Matsuura H; Uratani M; Okazaki K; Kishimoto T
    Psychiatry Res; 2016 Nov; 245():217-223. PubMed ID: 27552672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms of Obsessive-Compulsive Disorder during Pregnancy and the Postpartum Period: a Systematic Review and Meta-Analysis.
    Starcevic V; Eslick GD; Viswasam K; Berle D
    Psychiatr Q; 2020 Dec; 91(4):965-981. PubMed ID: 32445002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal Obsessive-Compulsive Disorder: Epidemiology, Phenomenology, Etiology, and Treatment.
    Hudepohl N; MacLean JV; Osborne LM
    Curr Psychiatry Rep; 2022 Apr; 24(4):229-237. PubMed ID: 35384553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsessions and Compulsions in Postpartum Women Without Obsessive Compulsive Disorder.
    Miller ES; Hoxha D; Wisner KL; Gossett DR
    J Womens Health (Larchmt); 2015 Oct; 24(10):825-30. PubMed ID: 26121364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and treatment of obsessive-compulsive disorder.
    Goodman WK; Lydiard RB
    J Clin Psychiatry; 2007 Dec; 68(12):e30. PubMed ID: 18162010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric obsessive-compulsive disorder: a guide to assessment and treatment.
    Keeley ML; Storch EA; Dhungana P; Geffken GR
    Issues Ment Health Nurs; 2007 Jun; 28(6):555-74. PubMed ID: 17613156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EXISTENTIAL OBSESSIONS: A CASE REPORT OF A POSTPARTUM OBSESSIVE COMPULSIVE DISORDER.
    Cordeiro-de-Medeiros AB; Fernandes-Dos-Santos CFS; Pimentel-Xavier SI
    Actas Esp Psiquiatr; 2022 Sep; 50(5):246-248. PubMed ID: 36273385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive-Compulsive Disorder: Diagnosis, Clinical Features, Nosology, and Epidemiology.
    Cervin M
    Psychiatr Clin North Am; 2023 Mar; 46(1):1-16. PubMed ID: 36740346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis.
    Hadi F; Kashefinejad S; Kamalzadeh L; Hoobehfekr S; Shalbafan M
    BMC Pharmacol Toxicol; 2021 Nov; 22(1):69. PubMed ID: 34736541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive-compulsive traits in children and adolescents with Asperger syndrome.
    Ruta L; Mugno D; D'Arrigo VG; Vitiello B; Mazzone L
    Eur Child Adolesc Psychiatry; 2010 Jan; 19(1):17-24. PubMed ID: 19557496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
    Besiroglu L; Çetinkaya N; Selvi Y; Atli A
    Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obsessive compulsive disorder--intrusive thoughts, impulses and repetitive behaviours as an expression of a significant disease].
    Weidt S; Rufer M; Brühl A; Baumann-Vogel H; Delsignore A
    Praxis (Bern 1994); 2013 Jul; 102(14):857-64. PubMed ID: 23823684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hoarding in obsessive-compulsive disorder and related disorders: a preliminary report of 15 cases.
    Seedat S; Stein DJ
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):17-23. PubMed ID: 11929567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpartum obsessive-compulsive disorder: prevalence and clinical characteristics.
    Zambaldi CF; Cantilino A; Montenegro AC; Paes JA; de Albuquerque TL; Sougey EB
    Compr Psychiatry; 2009; 50(6):503-9. PubMed ID: 19840587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of drug nonresponse in obsessive-compulsive disorder.
    Shetti CN; Reddy YC; Kandavel T; Kashyap K; Singisetti S; Hiremath AS; Siddequehusen MU; Raghunandanan S
    J Clin Psychiatry; 2005 Dec; 66(12):1517-23. PubMed ID: 16401151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive-compulsive disorder.
    Goodman WK; Grice DE; Lapidus KA; Coffey BJ
    Psychiatr Clin North Am; 2014 Sep; 37(3):257-67. PubMed ID: 25150561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.